**Abstract**

**Introduction:** Oxytocin may play a role mood regulation (1). Recent evidence found serum oxytocin levels of bipolar I disorder (BP I) patients in manic episode were significantly higher than those of the BP I patients in depressive episode or remission status, and also healthy subjects (2). However, if the difference existed between major depressive disorder (MDD) and BP II is unclear. This study aimed to investigate the serum oxytocin levels in drug-naïve MDD and BP II patients in their major depressive episodes before and after receiving pharmacological treatment.

**Methods**: 96 healthy controls (41 male, 55 female), 261 BP II and 97 MDD patients were enrolled. Plasma oxytocin levels were measured.

**Results**: The serum oxytocin level of the BP II patients (42.0±23.7) was significantly higher than those of the MDD patients (31.9±18.4, p \< .01) and controls (28.4±14.0, p \< 0.01). After treatment, the serum oxytocin level of BP II increased significantly (p \< 0.001). However, it remained unchanged in the MDD group.

**Conclusion**: The oxytocin level may be a biomarker of BP in either manic or depressive episodes. The increase of oxytocin levels might underlying a compensate process during the treatment course in BP II patients.
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